Bradley Canino
Stock Analyst at Stifel
(1.80)
# 2,992
Out of 4,827 analysts
94
Total ratings
29.11%
Success rate
-8.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $1.77 | +747.46% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $0.46 | +224.75% | 8 | Mar 7, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $3.05 | +655.34% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $6.79 | +651.10% | 6 | Feb 12, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $115 | $26.46 | +334.62% | 2 | Dec 3, 2024 | |
| AFMD Affimed | Maintains: Hold | $5 → $4 | $0.70 | +471.43% | 5 | Nov 15, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $40 → $41 | $11.14 | +268.04% | 5 | Oct 14, 2024 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $6.02 | +215.61% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $10.70 | +292.52% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $25.65 | +55.95% | 4 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $72.04 | +87.40% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.51 | +262.98% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.11 | +804.98% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $1.31 | +663.36% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $99 | $43.12 | +129.59% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $1.58 | +786.08% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $7.83 | +410.86% | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $130 | $100.01 | +29.99% | 5 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $30.88 | +78.11% | 4 | Feb 23, 2024 |
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $1.77
Upside: +747.46%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $0.46
Upside: +224.75%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $3.05
Upside: +655.34%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $6.79
Upside: +651.10%
Janux Therapeutics
Dec 3, 2024
Maintains: Buy
Price Target: $70 → $115
Current: $26.46
Upside: +334.62%
Affimed
Nov 15, 2024
Maintains: Hold
Price Target: $5 → $4
Current: $0.70
Upside: +471.43%
Syndax Pharmaceuticals
Oct 14, 2024
Maintains: Buy
Price Target: $40 → $41
Current: $11.14
Upside: +268.04%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $6.02
Upside: +215.61%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $10.70
Upside: +292.52%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $25.65
Upside: +55.95%
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $72.04
Upside: +87.40%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $5.51
Upside: +262.98%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.11
Upside: +804.98%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $1.31
Upside: +663.36%
Jun 17, 2024
Maintains: Buy
Price Target: $90 → $99
Current: $43.12
Upside: +129.59%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $1.58
Upside: +786.08%
May 1, 2024
Initiates: Buy
Price Target: $40
Current: $7.83
Upside: +410.86%
Apr 26, 2024
Maintains: Buy
Price Target: $120 → $130
Current: $100.01
Upside: +29.99%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $30.88
Upside: +78.11%